| Primary information |
|---|
| OV_ID | OV_3095 |
| Virus Name | Vaccinia virus |
| Strain | DeltaJ2R-I4L/FCU1 VACV (TG6002) |
| Virus type | DNA |
| Virus family | Poxviridae |
| Modification in virus genome | Deletion of J2R and I4L gene and insertion of gene FCU1 |
| Virus alone | Yes |
| Virus in combination iwth drug/radiation | No |
| Immune gene induction in virus genome | No |
| Source of cell line | ECACC |
| Origin of cell line | Human eosophageal cancer cell line |
| Cell line | OE19 |
| Concentration of cell line | 3 |
| In-vitro toxicity | NA |
| Assay | Trypan blue assay |
| In-vitro virus concentration | 10â»Â² MOI |
| In-vitro result | 5% cell viability |
| Model organism | No |
| In-vivo virus concentration | No |
| In-vivo toxicity | NA |
| In-vivo result | No response |
| Mode of delivery | NA |
| Pathway induction | NA |
| Immunogenic effect | NA |
| Clinical trial | NA |
| PMID | 31011628 |